WebFeb 1, 2024 · Purple Book to Include Patent and Additional Information on Biologic Drugs. by April Breyer Menon. February 1, 2024. As part of the “Consolidated Appropriations Act, 2024,” a COVID-19 relief and spending bill, 42 U.S.C. § 262 (k) was amended to include new provisions for the FDA’s Database of Licensed Biological Products (“Purple Book”). WebMay 7, 2024 · Rather, the Purple Book lists approved biological products, their date of approval, and any biosimilar or interchangeable biological products licensed by FDA. That could change if S. 659, also known as the “Biologic Patent Transparency Act,” becomes law. S. 659 would require the FDA to publish “a single, easily searchable, list” of ...
Taking Advantage of the New Purple Book Patent …
WebJun 15, 2024 · On June 25, 2024, the Biological Product Patent Transparency (BPPT) amendments to 42 U.S.C. 262 (k) of the Biologics Price Competition and Innovation Act … Web14 CENSED BIOLOGICAL PRODUCTS.— 15 ‘‘(i) PRODUCTS APPROVED UNDER 16 SECTION 351 OF THE PHSA.—Not later 17 than 30 days after the date of enactment 18 of the Biologic Patent Transparency Act, 19 the holder of a biological product license 20 that was approved under subsection (a) or 21 (k) before the date of enactment of such grant for training bc
Purple Book to Include Patent and Additional Information on …
WebJun 1, 2024 · FDA publishes certain information about listed biological products, including “the licensure status, and, as available, the marketing status,” 33 See section 351(k)(9)(A)(i)(III) of the PHS Act (42 U.S.C. § 262(k)(9)(A)(i)(III), as amended by Subtitle C, Section 325, the Biological Product Patent Transparency Act, of the Consolidated ... WebMar 5, 2024 · Biologic Patent Transparency Act. ... The list shall contain information including (1) the official and proprietary name of the product, (2) the patents the license holder has listed under this bill, (3) whether various market exclusivity periods apply to the product, and (4) information about whether the product is interchangeable with another ... WebFeb 15, 2024 · The Orange Book Transparency Act did little more than codify existing requirements and, despite new patent listing requirements for biological products, the Purple Book Continuity Act failed to ... grant for trucking school